Abstract Library

#980 ELECT: A Phase 3 Study of Efficacy and Safety of Lanreotide Autogel (LAN) Treatment for Carcinoid Syndrome (CS) in Patients (Pts) with Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)

Introduction: Somatostatin analogs (SSAs) are the mainstay treatment

Conference: 11th Annual ENETSConcerence (2014)

Presenting Author:

Authors: Gomez-Panzani E, Vinik A, Wolin E, Audry H,

Keywords: symptom control,

#595 A Single Fasting Plasma 5-HIAA Value Correlates with 24-Hour Urinary 5-HIAA Values and Other Biomarkers in Midgut Neuroendocrine Tumors (NETs)

Introduction: 5-hydoxyindoleacetic acid (5-HIAA) is used for the evaluation of neuroendocrine tumors (NETs), however, the current 5-HIAA assay requires a 24-hour urine collection which is inconvenient.

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author:

Authors: Tellez M, Mamikunian G, Go V, O'Dorisio T, Vinik A,

Keywords: 5 Hydroxyindoleacetic acid, 5-HIAA, neuroendocrine tumors, midgut, serotonin, carcinoid syndrome,